GlassScriptPhysician profile
Paul Michael Graham
NPI 1720406580
$2,405.98
in general payments reported to CMS, 2019-2025
21 companies · $524 in 2025
The $524 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54.81 · 2020: $350 · 2021: $358 · 2022: $220 · 2023: $434 · 2024: $464 · 2025: $524.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,422.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $378.43 | 2020-2025 | Tremfya |
| Sun Pharmaceutical Industries INC. | $274.84 | 2021-2024 | Ilumya |
| Genzyme Corporation | $233.91 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $230.21 | 2021-2025 | Dupixent, Libtayo |
| Allergan, INC. | $169.80 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $164.28 | 2024-2025 | |
| Pfizer INC. | $141.13 | 2020-2023 | |
| E.R. Squibb & Sons, L.L.C. | $134.43 | 2023-2024 | Sotyktu |
| Almirall LLC | $106.04 | 2023-2025 | Klisyri, Seysara |
| Galderma Laboratories, L.P. | $102.61 | 2019-2025 | Nemluvio |
| Abbvie INC. | $87.41 | 2023-2024 | |
| Hill Dermaceuticals, INC. | $80.93 | 2024 | Tolak |
| Smith+Nephew, INC. | $53.61 | 2023-2025 | Collagenase Santyl, Stravix Pl |
| Incyte Corporation | $49.92 | 2022-2025 | Opzelura |
| Ucb, INC. | $39.23 | 2025 | Bimzelx |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $37.37 | 2025 | Hadlima |
| Mimedx Group, INC. | $29.32 | 2024-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $24.16 | 2025 | Cabtreo, Jublia |
| Leo Pharma INC. | $23.82 | 2022 | |
| Lilly USA, LLC | $23.01 | 2024 | Taltz, Olumiant |
| Amgen INC. | $21.52 | 2023 | Otezla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Graham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.